Dr Dayna Johnson: Mindfulness Can Help Facilitate Better Sleep and Health Outcomes
June 6th 2023Dayna Johnson, PhD, MPH, MSW, MS, the Rollins School of Public Health at Emory University, discusses principal findings from the analysis of a 35-day sleep intervention study that utilized a mobile mindfulness app to manage stress and anxiety combined with healthy sleep practices.
Watch
Dr Ariel Williamson: Family Environment Is Crucial When Tailoring Sleep Interventions
June 6th 2023It’s important to consider the social context, the social ecology, and the family environment when investigating behavioral sleep problems among children and adults, noted Arielle Williamson, PhD, DBSM, Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine.
Watch
More Work Is Needed to Bring Clinical Trials to Underserved Patients, ASCO Panel Says
June 6th 2023While efforts are underway to improve access to cutting-edge oncology clinical trials for underserved patients, more work is needed to get the job done, said a panel of experts at the 2023 American Society of Clinical Oncology Annual Meeting.
Read More
ZUMA-7 Findings Show Earlier Is Better for Axi-Cel Use in R/R LBCL, Says Dr Jason Westin
June 5th 2023Jason Westin, MD, MS, FACP, director of the Lymphoma Clinical Research Program at the University of Texas MD Anderson Cancer Center, gave insight the ZUMA-7 trial of axicabtagene ciloleucel (axi-cel) in relapsed or refractory large B-cell lymphoma (R/R LBCL) and the study's implications in the broader LBCL landscape.
Watch
Dr Judy Wang on the Potential of CLN-619 for the Treatment of Solid Tumors
June 5th 2023Judy Wang, MD, medical oncologist and clinical trials investigator at Sarah Cannon Research Institute at Florida Cancer Specialists & Research Institute, discussed the mechanism of action and rationale for studying CLN-619, an anti-MICA/B antibody, with and without pembrolizumab in patients with solid tumors.
Watch
Dr Bhagirathbhai Dholaria Discusses TRiMM-2 Trial Findings
June 4th 2023Bhagirathbhai R. Dholaria, MD, assistant professor of medicine in the Department of Hematology-Oncology at Vanderbilt University Medical Center, discussed findings from the phase 2 TRiMM-2 trial of talquetamab plus daratumumab in multiple myeloma.
Watch
Social Determinants of Health Impact Germline Testing Rates Among Patients With TNBC
June 4th 2023Barb Kunz, MS, LCGC, senior genetic counselor at the US Oncology Network, shared insight on a study of social determinants of health in the context of germline genetic testing for triple-negative breast cancer (TNBC) in the community oncology setting.
Watch
Osimertinib Shows Significant OS Benefit in Patients With Resected, EGFRm NSCLC
June 4th 2023Roy S. Herbst, MD, PhD, deputy director of Yale Cancer Center and lead investigator for ADAURA, said the results erase any doubts about the use of osimertinib in early non–small cell lung cancer (NSCLC) for patients with EGFR mutations.
Read More
Dr Dennis Slamon on What Sets the NATALEE Trial Apart From Other Breast Cancer Studies
June 3rd 2023Dennis Slamon, MD, PhD, lead investigator on the NATALEE trial of ribociclib plus hormonal therapy in hormone receptor–positive, HER2-negative early-stage breast cancer, discussed the study's broad population and potential payer reactions.
Watch
Dr Surya Bhatt Discusses the Role of Dupilumab in Type 2 Inflammation, Exacerbations in COPD
June 2nd 2023Surya Bhatt, MD, associate professor of medicine at University of Alabama at Birmingham, talks about a new trial in which dupilumab was used in patients with chronic obstructive pulmonary disease (COPD) with frequent exacerbations and type 2 inflammation.
Watch
EHA 2023 to Augment Trial Results With the Voice of the Patient
June 1st 2023The 2023 European Hematology Association (EHA) Congress, convening virtually and in Frankfurt, Germany, from June 8-11, 2023, will feature cutting-edge findings in oncology and hematology, with a special focus on incorporating patient-reported outcomes and real-world data.
Read More
Dr Joseph Mikhael Previews EHA 2023, His Presentation on the Future of MM Care
June 1st 2023Attendees will gain insight into the future of multiple myeloma (MM) therapies and updates on pivotal clinical trials at the 2023 European Hematology Association (EHA) Congress, according to Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation.
Read More
Dr Rebecca Spencer Highlights How SLEEP 2023 Will Bridge Basic and Clinical Science
May 31st 2023In this preview interview for SLEEP 2023, Rebecca Spencer, PhD, chair of the Associated Professional Sleep Societies Program Committee, highlights how bringing patients and clinicians together can inspire new ideas in sleep medicine.
Watch
ASCO 2023 to Highlight Treatment Options, Partnerships With Patients in Guiding Cancer Care
May 30th 2023The cancer care community descends on Chicago this weekend for the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO). This year’s theme, “Partnering With Patients: The Cornerstone of Cancer Care and Research,” highlights how recent advances make interactions between clinicians and patients more important than ever, as shared decision-making must be the foundation of the care journey.
Read More
Dr Lalan Wilfong on Learnings From the OCM and Challenges Ahead of the EOM
May 30th 2023Lalan Wilfong, MD, senior vice president of payer and care transformation at The US Oncology Network, shared insight into lessons learned from the Oncology Care Model (OCM) and looked ahead to the Enhancing Oncology Model (EOM) ahead of a panel discussion at the 2023 ASCO Annual Meeting.
Watch
Dr Andrew Evens on the SWOG S1826 Trial and Changing Landscape of Hodgkin Lymphoma
May 30th 2023Andrew Evens, DO, MBA, MSc, associate director for clinical services at Rutgers Cancer Institute, discussed the ways in which SWOG S1826 trial results will build on current knowledge of Hodgkin lymphoma treatment.
Watch
Dr Chitra Lal: Low Threshold Screening Needed for OSA
May 25th 2023Chitra Lal, MD, D-ABSM, FCCP, FAASM, FACP, ATSF, professor of medicine at Medical University of South Carolina, says that the screening threshold for obstructive sleep apnea (OSA) should be low because 70% to 75% of patients with mild cognitive impairment have sleep apnea.
Watch